ES2110499T3 - Intermediario opticamente activo y su produccion. - Google Patents

Intermediario opticamente activo y su produccion.

Info

Publication number
ES2110499T3
ES2110499T3 ES92910210T ES92910210T ES2110499T3 ES 2110499 T3 ES2110499 T3 ES 2110499T3 ES 92910210 T ES92910210 T ES 92910210T ES 92910210 T ES92910210 T ES 92910210T ES 2110499 T3 ES2110499 T3 ES 2110499T3
Authority
ES
Spain
Prior art keywords
optically active
production
represents hydrogen
active intermediary
cn2s
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910210T
Other languages
English (en)
Inventor
Toshiro Konoike
Yoshitaka Araki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2110499T3 publication Critical patent/ES2110499T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/535—Organo-phosphoranes
    • C07F9/5352—Phosphoranes containing the structure P=C-
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA SINTETIZAR UN MATERIAL DE PARTIDA ACTIVO OPTICAMENTE, REPRESENTADO POR LA FORMULA GENERAL (I), PARA DIFERENTES MEDICINAS CON UNA ELEVADA PUREZA OPTICA CON BUEN RENDIMIENTO, EN LA QUE R1 REPRESENTA HIDROGENO O GRUPO PROTECTOR HIDROXILO: * REPRESENTA UN ATOMO DE CARBON ASIMETRICO; R2 REPRESENTA HIDROGENO O ALQUILO MAS BAJO SUSTITUIDO OPCIONALMENTE; Y Q REPRESENTA -C = P(PH)3, -CH2P(P)(OME)2 O -CN2S(O)ME. MAS PARTICULARMENTE, UN PRODUCTO INTERMEDIO PARA LA SINTESIS DE UN COMPUESTO ACTIVO OPTICAMENTE UTIL PAA INHIBIR LA ACTIVIDAD DE LA REDUCTASA HMG-COA PARA INHIBIR POR ELLO LA BIOSINTESIS DE COLESTEROL; Y UN PROCESO PARA PRODUCIR EL PRODUCTO INTERMEDIO.
ES92910210T 1991-06-19 1992-05-14 Intermediario opticamente activo y su produccion. Expired - Lifetime ES2110499T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17620991 1991-06-19

Publications (1)

Publication Number Publication Date
ES2110499T3 true ES2110499T3 (es) 1998-02-16

Family

ID=16009533

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910210T Expired - Lifetime ES2110499T3 (es) 1991-06-19 1992-05-14 Intermediario opticamente activo y su produccion.

Country Status (11)

Country Link
US (1) US5354879A (es)
EP (1) EP0554455B1 (es)
JP (2) JP3233403B2 (es)
KR (1) KR100216011B1 (es)
AT (1) ATE161262T1 (es)
DE (1) DE69223603T2 (es)
DK (1) DK0554455T3 (es)
ES (1) ES2110499T3 (es)
GR (1) GR3026204T3 (es)
TW (1) TW201730B (es)
WO (1) WO1992022560A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717124A (en) * 1993-03-30 1998-02-10 Ube Industries, Ltd. Process for preparation of oxyglutaric acid ester derivatives
DE69424463T2 (de) * 1993-03-30 2000-09-14 Ube Industries, Ltd. Verfahren zur Herstellung von Ester-Derivaten der Oxyglutar-Säure
US6376476B1 (en) * 1996-12-13 2002-04-23 Zymogenetics Corporation Isoprenoid pathway inhibitors for stimulating bone growth
US6121475A (en) * 1999-09-17 2000-09-19 Ube Industries, Ltd. Preparation of optically active β-hydroxyester derivatives and platinum-containing catalyst
KR100511533B1 (ko) * 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
GB0211751D0 (en) * 2002-05-22 2002-07-03 Avecia Ltd Compound and process
CA2657076A1 (en) * 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin calcium
US7777034B2 (en) * 2003-11-24 2010-08-17 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
ES2364143T3 (es) * 2003-12-02 2011-08-25 Teva Pharmaceutical Industries Ltd. Estandar de referencia para caracterización de rosuvastatina.
US7851624B2 (en) 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
CA2573857A1 (en) * 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
TWI345562B (en) 2005-02-22 2011-07-21 Teva Pharma Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
MX2007004427A (es) * 2005-08-16 2007-06-14 Teva Pharma Intermedio de rosuvastatina cristalina.
CN1958593B (zh) * 2005-11-03 2010-05-05 上海医药工业研究院 一种用于合成瑞舒伐他汀钙的中间体的制备方法
JP2009531466A (ja) 2007-04-18 2009-09-03 テバ ファーマシューティカル インダストリーズ リミティド ＨＭＧ−ＣｏＡ還元酵素阻害剤の中間体の製造方法
EP2178890A1 (en) * 2007-07-12 2010-04-28 Teva Pharmaceutical Industries Ltd. Purification of rosuvastatin intermediate by thin film evaporation and chemical method
EA201000214A1 (ru) 2007-08-28 2010-10-29 Рациофарм Гмбх Способ получения производных пентадикарбоновой кислоты
CN101735272B (zh) * 2009-12-11 2012-10-31 重庆博腾制药科技股份有限公司 瑞舒伐他汀钙中间体的制备方法
EP2785851A2 (en) * 2011-11-28 2014-10-08 Mylan Laboratories, Limited Process for producing chiral statin side chain intermediates employing candida antarctica lipase b

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421555A (en) * 1972-03-17 1976-01-21 Searle & Co Process for the stereoselective production of intermediates in the synthesis of pge1 and derivatives
US3907852A (en) * 1972-06-23 1975-09-23 Exxon Research Engineering Co Silylhydrocarbyl phosphines and related compounds
DE3722807A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
WO1989003212A1 (en) * 1987-10-13 1989-04-20 Pfizer Inc. 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
US4804770A (en) * 1988-04-29 1989-02-14 E. R. Squibb & Sons, Inc. Process for preparing a keto-phosphonate intermediate useful in preparing HMG-CoA reductase inhibitors
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
US5117039A (en) * 1988-12-14 1992-05-26 Shionogi & Co., Ltd. Monoesters of arylacetic acid and the process thereof
JP2719723B2 (ja) * 1988-12-14 1998-02-25 塩野義製薬株式会社 アリール酢酸モノエステル類およびその製造法
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives

Also Published As

Publication number Publication date
JP3635247B2 (ja) 2005-04-06
JP2002088054A (ja) 2002-03-27
ATE161262T1 (de) 1998-01-15
GR3026204T3 (en) 1998-05-29
DK0554455T3 (da) 1998-01-19
EP0554455A4 (es) 1994-03-23
EP0554455A1 (en) 1993-08-11
JP3233403B2 (ja) 2001-11-26
KR930701460A (ko) 1993-06-11
US5354879A (en) 1994-10-11
TW201730B (es) 1993-03-11
EP0554455B1 (en) 1997-12-17
DE69223603T2 (de) 1998-04-09
WO1992022560A1 (en) 1992-12-23
DE69223603D1 (de) 1998-01-29
KR100216011B1 (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
ES2110499T3 (es) Intermediario opticamente activo y su produccion.
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
NO991019D0 (no) 3-merkapto-1-(1,3-tiazolin-2-yl)azetidin-derivater
ES2157214T3 (es) Procedimiento para producir derivados de azetidinona sustituidos en posicion 4.
ATE122334T1 (de) 4-(4-alkoxyphenyl)-2-butylaminderivate und deren herstellungsverfahren.
DK1466905T3 (da) Fremgangsmåde til fremstilling af en optisk aktiv oxoheptensyreester
IL119130A0 (en) Production of optically active 2-halo-1- (substituted phenyl) ethanol and substituted styrene oxide
AU689459B2 (en) Process for the preparation of aminotriazine derivatives
ES2060545A1 (es) Un procedimiento para producir un derivado de benzo(b)tiofen-5-ilo opticamente activo.
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
ES2033313T3 (es) Procedimiento de sintesis de azetidinonas.
DK11788D0 (da) Stereobevarende syntese af 1-substituerede (s)- og (r)-2-aminometylpyrrolidiner og mellemprodukter dertil
PT916656E (pt) Metodo para producao de derivados de pirrolidinona
FI942167A0 (fi) Optisesti aktiivinen 1-fenyylipyrrolidonijohdannainen, välituote sen valmistamiseksi ja menetelmä molempien valmistamiseksi
WO2005046854A3 (en) A process for the preparation of diphenylmethylsulfinyl derivatives
ES8404989A1 (es) Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 554455

Country of ref document: ES